Protein Engineering Market Research Report Detailed Analysis and Forecast 2025

Protein Engineering Market Research Report Detailed Analysis
and Forecast 2025
“Protein engineering is a method to design novel proteins or
enzymes with the intention to have functional properties.
Protein engineering is primarily based on the use of recombinant
DNA technology to alter the amino acid sequences in terms of
affinity, solubility, activity, resistance.”
Global Protein Engineering Market is anticipated to reach USD 3.09 billion by 2025. Protein engineering is a
method to design novel proteins or enzymes with the intention to have functional properties. Protein
engineering is primarily based on the use of recombinant DNA technology to alter the amino acid sequences in
terms of affinity, solubility, activity, resistance, etc.
The factors that propel the growth of the Protein Engineering industry include increasing occurrence of lifestyle
associated diseases, increasing consciousness regarding healthcare, increasing healthcare expenditure, and
growing adoption of protein-based drugs. On the other hand, there are factors that may hamper the growth of
the market including lack of skilled expertise, maintenance, and high price of tools as well as instruments utilized
during protein engineering. Protein Engineering Market is anticipated to grow at a significant CAGR of 15.9% in
the upcoming period as the scope, product types, and its applications are increasing across the globe.
The market may be explored by product type, technology, protein type, end users, and geography. The market
may be explored by product type as services and software, instruments, and reagents. The “Instruments”
segment dominated the market in 2016 and is anticipated to maintain its dominance in the forecast period.
The key technologies that could be explored in the Protein Engineering industry include Irrational Protein
Design, and Rational Protein Design. The “Rational Protein Design” segment dominated the market in 2016 and
is anticipated to maintain its dominance by 2025 owing to highly accepted technology in the market in 2014.
This huge share could be ascribed to its advantages over irrational protein design technology.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/protein-engineering-market/request-sample

The Protein Engineering Market could be explored based on protein type as Insulin, Erythropoietin, Vaccines,
Monoclonal Antibodies, Interferon, Growth hormones, Colony Stimulating factor, Coagulation Factor, Others
(Follicle Stimulating Hormones, Enzyme Replacement, and Interleukins). The “Monoclonal Antibodies” segment
dominated the market in 2016 and is anticipated to maintain its dominance by 2025 owing to increase in
acceptance for several treatments such as autoimmune diseases, and cancer.
Protein Engineering industry could be analyzed by end user as contract research organizations, academic
research institutes, and pharmaceutical & biotechnology companies. The “Pharmaceutical and Biotechnology
Companies” segment dominated the market. The factors contributing to the dominant share include increase
in R&D funds in the pharmaceutical segment, and technological advancements in protein engineering.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/protein-engineering-market
North America is anticipated to hold the major share of the Protein Engineering Market. The factors that
attribute to the dominant share include growing occurrence of diseases and rising adoption of protein-based
drugs in the region. The North American market is followed by Europe. On the other hand, Asia Pacific is
estimated to show high growth rates in the upcoming period in the global market. In the Asia Pacific region,
countries such as China and India are expected to be the fastest-growing markets.
Some of the key players that fuel the growth of the Protein Engineering industry comprise Eli Lilly and Company,
Thermo Fisher Scientific Inc., Merck KGaA, Bruker Corporation, PerkinElmer Inc., Agilent Technologies, Waters
Corporation, Novo Nordisk A/S, Bio-Rad Laboratories Inc., Amgen Inc., and among others. The leading
companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the
inorganic growth of the industry.
Market Segment:
Technology Outlook (Revenue, USD Million, 2014 - 2025)
• Rational Protein Design
• Directed Evolution
• Hybrid Approach
Product Outlook (Revenue, USD Million, 2014 - 2025)
• Instruments
• Reagents

• Software & Services
Protein Type Outlook (Revenue, USD Million, 2014 - 2025)
• Insulin
• Monoclonal Antibodies
• Vaccines
• Growth Factors
• Colony Stimulating Factors
• Coagulation Factors
• Interferon
• Others
End-use Outlook (Revenue, USD Million, 2014 - 2025)
• Academic Research Institutes
• CROs
• Pharma & Biotech Companies
Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan

• China
• India
• Latin America
• Mexico
• Brazil
• Middle East & Africa
• South Africa
See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/biotechnology
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our
representatives strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: sales@millioninsights.com
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016
India
Phone: 91-20-65300184